Verastem: Navigating Critical Steps In Commercialization And Development (Downgrade) [Seeking Alpha]
Verastem, Inc. (VSTM)
Last verastem, inc. earnings: 10/29 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
verastem.com
Company Research
Source: Seeking Alpha
Recent data from World Lung showcase the striking potential of their KRAS G12D inhibitor as well, although this is still going to take a long time to mature. Despite the promise here, the high operational costs and recent rapid share price rise suggest that the stock price is running hot, and a more favorable near-term entry is likely. Despite the rating downgrade, I think VSTM should absolutely be on your watchlist. Borisovna art/iStock via Getty Images Topline Summary and Update I have found a lot of things to be optimistic about with respect to the Verastem ( NASDAQ: VSTM ) investment thesis in past articles, including my most recent one focusing This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than
Show less
Read more
Impact Snapshot
Event Time:
VSTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VSTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VSTM alerts
High impacting Verastem, Inc. news events
Weekly update
A roundup of the hottest topics
VSTM
News
- Verastem Oncology to Present at the 8th Annual Evercore Healthcare ConferenceBusiness Wire
- Verastem (NASDAQ:VSTM) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded WarrantsBusiness Wire
- Verastem Oncology to Present at Upcoming Investor ConferencesBusiness Wire
- Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
VSTM
Earnings
- 11/4/25 - Miss
VSTM
Sec Filings
- 12/4/25 - Form 4
- 12/1/25 - Form 4
- 11/25/25 - Form 4
- VSTM's page on the SEC website